Teton Advisors, Inc. Collegium Pharmaceutical, Inc Transaction History

Teton Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$15.78 - $20.82 $314,022 - $414,318	-19,900 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $30,980 - $47,020	-2,000 Reduced 9.13%	19,900 $348,000
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $230,049 - $478,159	-21,500 Reduced 49.54%	21,900 $451,000
Q3 2019 Nov 01, 2019	SELL	$10.16 - $13.28 $40,640 - $53,120	-4,000 Reduced 8.44%	43,400 $498,000
Q2 2019 Aug 02, 2019	SELL	$10.62 - $16.59 $5,310 - $8,295	-500 Reduced 1.04%	47,400 $623,000
Q4 2018 Jan 30, 2019	BUY	$14.78 - $19.68 $394,626 - $525,456	26,700 Added 125.94%	47,900 $822,000
Q3 2018 Nov 02, 2018	SELL	$14.16 - $24.3 $152,928 - $262,440	-10,800 Reduced 33.75%	21,200 $312,000
Q4 2017 Feb 02, 2018	BUY	$9.3 - $19.14 $46,500 - $95,700	5,000 Added 18.52%	32,000 $591,000
Q3 2017 Nov 01, 2017	BUY	$9.15 - $11.97 $247,050 - $323,190	27,000	27,000 $283,000

236

39.4M

84.2K

18.6K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.31B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Teton Advisors, Inc. with notifications on news.